Is Biden a Trojan Horse for Single-Payer?
Townhall | Sally C. Pipes
October 29, 2020
Support for the idea evaporates quickly once Americans learn the details. Upon hearing that Medicare for All would eliminate private insurance or raise taxes, support drops to just 37 percent. A single-payer system that results in delays for tests and treatments garners the support of just 26 percent of Americans. Meanwhile, 71 percent of those with employer-sponsored insurance say that they’re satisfied with their coverage.
|
|
Fine-Tuning Treatments For COVID-19
American Council on Science and Health | Henry Miller, M.S., M.D.
October 30, 2020
While evidence suggests these drugs may be effective (and remdesivir just received full marketing approval from the FDA), there are other potential game-changers that have not yet attracted much attention; in fact, almost 2,000 clinical trials of drugs and vaccines (mostly the former) have been registered on the federal government’s database. Many of these focus on individuals’ immune system, either by eliciting an immune response (vaccines) or modulating it, in order that a response is not deleterious.
|
|
Make relaxed state-based telehealth restrictions permanent
The Tennessean | Sally C. Pipes
November 2, 2020
This scenario may seem absurd. But it’s an apt analogy for the regulatory regime governing many U.S. doctors. Telemedicine technology has made it easier than ever for physicians to provide care from afar. But thanks to onerous medical licensing rules, a doctor’s ability to practice medicine often vanishes when at the state border.
|
|
|
|
